Concepedia

Yingcheng Lin

YL

11

Publications

506

Citations

10

H-Index

2004

Active since

Affiliations

Shantou University(Current)

Cancer Hospital of Shantou University Medical College

Sun Yat-sen University Cancer Center

Sun Yat-sen University

First People's Hospital of Foshan

Yingcheng Lin is an author at Shantou University specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2004–2025

11

Publications

11

Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy

He Huang, Xueying Li, Jun Zhu et al. · JAMA · 2014 · 229 citations

Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safety

Hui Luo, Yuanfang Li, W. Wang et al. · Annals of Oncology · 2016 · 90 citations

, , +8

Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells

Xu‐Yuan Li, Yingcheng Lin, Wan-lan Huang et al. · Medical Oncology · 2011 · 37 citations

, , +10

Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

Xueying Li, He Huang, Bing Xu et al. · Cancer Research and Treatment · 2018 · 37 citations · Full text

Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study

Yuankai Shi, Shiman Wu, Ke Wang et al. · Journal of Thoracic Oncology · 2022 · 27 citations · Full text

Rows per page

1–5 of 11